Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2025 and updated financial ...

In the realm of modern combat and tactical self-defense, few names carry the presence and raw intensity of Michael “Shockwave” Johnson. Known in elite circles a ...

A leading authority on Cryptosporidium has warned of an urgent need for greater awareness and more fundamental research of ...

Xywav® and Epidiolex® revenues grew 9% and 10% year-over-year, respectively, in 1Q25 -- Completed submission of sNDA for Zepzelca® in 1L ES-SCLC -- ...

Slideshows ...